Reimagining Dinosaurs
Our perception of dinosaurs is changing. Peyton Cherry discusses how recent scientific evidence is helping us to reimaging what our favourite dinosaurs looked like and how they lived.
Continue reading
The importance of measuring patient voices in healthcare
Rakhshan Kamran discusses how patient-reported outcome measures should be applied in gender-affirming care and other healthcare settings.
Is there a cure for long COVID?
New research shows that more than 2 million people in the UK are now suffering from long COVID. Megan Perry discusses what might be causing the condition and how scientists are trying to cure it.
Innate-like T-cells: a New Weapon in Cancer Immunotherapy?
New research has found a novel population of T-cells that may be more successful than current immunotherapy treatments at targeting cancer cells. James O’Brien discusses.
The Secret Life of the Ocean’s Green Giants
By Joel Tester The title of Earth’s largest living organism may bring to mind classic examples like giant sequoias or blue whales. Yet, in a recently published paper, researchers at the University of Western Australia revealed an unexpected new winner of this accolade. The scientists studied a 180 km2 meadow of the seagrass Posidonia australis…
Is green social prescribing the future of health?
For years medications have been overprescribed by doctors, costing millions and harming the environment. Amy Booth discusses how green social prescribing may be the answer to reduce these costs and help support people with nature-based interventions.
Should we ban wildlife trade? The consequences of a global ban of wildlife trade on public health
Toscanie Hulett comments on the consequences of wildlife trade on public health, and whether a blanket ban of the trade would actually be detrimental to sustainable development.
Can we control the power of the human genome?
Max Cowan explores the possibilities created by human genome sequencing and the considerations that need to be put in place for its widespread and commercial use.
AD: SALVO – Oxford Vaccine Group
Help us investigate the first ever vaccine for Invasive Non-Typhoid Salmonella (iNTS) – The SALVO Trial You are invited to take part in a study to investigate a new vaccine for invasive non-Typhoid Salmonella (iNTS) disease. The study is being run by the Oxford Vaccine Group which is part of the University of Oxford. If you are aged…
AD: VASP – Oxford Vaccine Group
Would you like to help us investigate Paratyphoid Fever? If you are aged 18 to 55 years old, and in good health, you may be eligible to take part in the study. We will provide reimbursement for your time, inconvenience, and travel. Participants will receive up to £2965 if they remain in the study for…